VitaHealth Analysis
Expanded Cancer Panel – Female

 

VitaHealth Analysis Expanded Cancer Panel – Female

What’s it used for?
The test is used to provide information regarding indicators for three common cancers that affect women, including ovarian, colon, rectal, and breast cancer.
The presence of the carcinoembryonic antigen (CEA) in the blood may indicate certain kinds of cancers, typically colon and rectal, but sometimes pancreas, breast or lung. Cancer antigen (CA) 125 and CA 27-29 are tumor markers for ovarian cancer and breast cancer respectively.

VitaHealth Analysis

Expanded Cancer Panel - Female

Carcinoembryonic Antigen (CEA) CEA is associated with certain kinds of cancers, especially colon and rectal cancer. Elevated CEA levels are also found with other cancers including pancreatic, gastric, lung, ovary, and breast
Cancer Antigen (CA) 27.29 The CA 27.29 is the premier blood test for breast cancer. In fact, the CA 27.29 is the only blood test specific for breast cancer
Cancer Antigen CA-125 CA 125 is the premier test for the diagnosis and management of ovarian cancer

Book a Consultation

  • Contact Information

  • Services

  • Date Format: MM slash DD slash YYYY
    Tuesday – Thursday: 10am-7pm
    Friday – Saturday: 10am-6pm
    Sunday – Monday: Closed
Menu